Avalon GloboCare (NASDAQ:ALBT) Announces Earnings Results

Avalon GloboCare (NASDAQ:ALBT) announced its quarterly earnings results on Tuesday. The company reported ($1.43) earnings per share for the quarter, Zacks reports.

Avalon GloboCare Stock Down 2.1%

Shares of ALBT stock opened at $3.79 on Wednesday. The firm’s 50 day moving average price is $4.39 and its two-hundred day moving average price is $4.08. Avalon GloboCare has a fifty-two week low of $2.11 and a fifty-two week high of $21.60. The stock has a market cap of $6.26 million, a price-to-earnings ratio of -0.19 and a beta of 0.16.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.